blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1492796

EP1492796 - SUBSTITUTED AMINO ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS. [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.07.2008
Database last updated on 03.10.2024
Most recent event   Tooltip23.07.2010Lapse of the patent in a contracting state
New state(s): HU		published on 25.08.2010  [2010/34]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2007/36]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Former [2005/01]For all designated states
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / ANDRÉS-GIL, José, Igancio Janssen-Cilag S.A.
Calle Jarama (S/N), Poligono Industrial
E-45007 Toledo / ES
02 / ALCÁZAR-VACA, Manuel, Jesú Janssen-Cilag S.A.
Calle Jarama (S/N), Poligono Industrial
E- 45007 Toledo / ES
03 / BAKKER, Margaretha Henrica Maria
Janssen Pharmaceutica N.V., Turnhoutseweg 30
B-2340 Beerse / BE
04 / DE LUCAS OLIVARES, Ana, Isabel Janssen-Cilag SA
Calle Jarama (S/N), Poligono Industrial
E-45007 Toledo / ES
 [2007/36]
Former [2005/16]01 / Andres-Gil, José, Janssen-Cilag S.A.
Calle Jarama (S/N), Poligono Industrial
E-45007 Toledo / ES
02 / Alcazar-Vaca, M., Janssen-Cilag S.A.
Calle Jarama (S/N), Poligono Industrial
E- 45007 Toledo / ES
03 / Bakker, Margaretha Henrica Maria
Janssen Pharmaceutica N.V., Turnhoutseweg 30
B-2340 Beerse / BE
04 / De Lucas Olivares, A., Janssen-Cilag SA
Calle Jarama (S/N), Poligono Industrial
E-45007 Toledo / ES
Former [2005/01]01 / Andres-Gil, José, Janssen-Cilag S.A., Edif. J.&J.
P/ de las Doce Estrellas 5-7, Campo de Naciones
E-28042 Madrid / ES
02 / Alcazar-Vaca, M., Janssen-Cilag S.A., Edif. J.&J.
P/o de las Doce Estrella5-7, Campo de Naciones
E- 28042 Madrid / ES
03 / Bakker, Margaretha Henrica Maria
Janssen Pharmaceutica N.V., Turnhoutseweg 30
B-2340 Beerse / BE
04 / De Lucas Olivares, A., Janssen-Cilag SA, Edif. J&J
P/o de las Doce Estrellas 5-7, Campo de Naciones
E-28042 Madrid / ES
Representative(s)Daelemans, Frank F.R., et al
Janssen Pharmaceutica N.V. J&J Patent Law Department Turnhoutseweg 30
2340 Beerse / BE
[2007/43]
Former [2005/01]Van Borm, Werner, et al
Janssen Pharmaceutica N.V. J & J Patent Law Department Beerse Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date03714897.027.03.2003
[2005/01]
WO2003EP03245
Priority number, dateEP2002007623902.04.2002         Original published format: EP 02076239
[2005/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03082878
Date:09.10.2003
Language:EN
[2003/41]
Type: A1 Application with search report 
No.:EP1492796
Date:05.01.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2003 takes the place of the publication of the European patent application.
[2005/01]
Type: B1 Patent specification 
No.:EP1492796
Date:05.09.2007
Language:EN
[2007/36]
Search report(s)International search report - published on:EP09.10.2003
ClassificationIPC:C07D498/04, C07D498/14, C07D261/20, A61K31/424, A61K31/5383, C07D311/00
[2005/01]
CPC:
C07D498/04 (EP,KR,US); A61P25/00 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P3/04 (EP); A61P43/00 (EP); C07D498/14 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
Extension statesAL02.11.2004
LT02.11.2004
LV02.11.2004
MK02.11.2004
TitleGerman:SUBSTITUIERTE AMINOISOXAZOLINDERIVATE UND IHRE VERWENDUNG ALS ANTIDEPRESSIVA[2005/01]
English:SUBSTITUTED AMINO ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS.[2005/01]
French:DERIVES D'AMINO ISOXAZOLINE SUBSTITUES ET UTILISATION DE CEUX-CI EN TANT QU'ANTIDEPRESSEURS[2005/01]
Entry into regional phase02.11.2004National basic fee paid 
02.11.2004Designation fee(s) paid 
02.11.2004Examination fee paid 
Examination procedure04.09.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.11.2004Examination requested  [2005/01]
25.04.2006Despatch of a communication from the examining division (Time limit: M04)
01.08.2006Reply to a communication from the examining division
19.02.2007Communication of intention to grant the patent
02.07.2007Fee for grant paid
02.07.2007Fee for publishing/printing paid
Opposition(s)06.06.2008No opposition filed within time limit [2008/33]
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
31.03.2006Renewal fee patent year 04
02.04.2007Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.09.2007
CZ05.09.2007
EE05.09.2007
FI05.09.2007
SI05.09.2007
SK05.09.2007
BG05.12.2007
HU06.03.2008
MC31.03.2008
[2010/34]
Former [2009/39]CY05.09.2007
CZ05.09.2007
EE05.09.2007
FI05.09.2007
SI05.09.2007
SK05.09.2007
BG05.12.2007
MC31.03.2008
Former [2009/34]CY05.09.2007
CZ05.09.2007
EE05.09.2007
FI05.09.2007
SI05.09.2007
SK05.09.2007
MC31.03.2008
Former [2009/29]CZ05.09.2007
EE05.09.2007
FI05.09.2007
SI05.09.2007
SK05.09.2007
MC31.03.2008
Former [2009/11]CZ05.09.2007
EE05.09.2007
FI05.09.2007
SK05.09.2007
MC31.03.2008
Former [2008/46]CZ05.09.2007
FI05.09.2007
SK05.09.2007
MC31.03.2008
Former [2008/25]CZ05.09.2007
FI05.09.2007
SK05.09.2007
Former [2008/10]FI05.09.2007
Cited inInternational search[Y]WO9725317  (HOECHST MARION ROUSSEL INC [US]) [Y] 1-7,9-18 * the whole document *;
 [Y]EP0885883  (YOSHITOMI PHARMACEUTICAL [JP]) [Y] 1-7,9-18 * the whole document, particularly examples 97, 98 and 105 *;
 [PX]WO02066484  (JANSSEN PHARMACEUTICA NV [BE], et al) [PX] 1-7,9-18* the whole document *;
 [X]  - O'NEIL M J, SENIOR EDITOR, The Merck Index, thirteenth edition, WHITEHOUSE STATION, NJ, US, MERCK & CO., INC., (2001), XP002246908 [X] 15 * page 741, monography 4211 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.